TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging

Barron, 1995, The microglial cell. A historical review, J. Neurol. Sci., 134, 57, 10.1016/0022-510X(95)00209-K Bayle, 2006, Rapamycin analogs with differential binding specificity permit orthogonal control of protein activity, Chem. Biol., 13, 99, 10.1016/j.chembiol.2005.10.017 Berger, 2014, Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice, J. Immunol., 192, 5476, 10.4049/jimmunol.1400499 Bonnard, 2000, Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription, EMBO J., 19, 4976, 10.1093/emboj/19.18.4976 Caccamo, 2017, Necroptosis activation in Alzheimer’s disease, Nat. Neurosci., 20, 1236, 10.1038/nn.4608 Chen, 2012, Ubiquitination in signaling to and activation of IKK, Immunol. Rev., 246, 95, 10.1111/j.1600-065X.2012.01108.x Cho, 2009, Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation, Cell, 137, 1112, 10.1016/j.cell.2009.05.037 Cirulli, 2015, Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways, Science, 347, 1436, 10.1126/science.aaa3650 Conde, 2006, Microglia in the aging brain, J. Neuropathol. Exp. Neurol., 65, 199, 10.1097/01.jnen.0000202887.22082.63 Cox, 2008, MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification, Nat. Biotechnol., 26, 1367, 10.1038/nbt.1511 Degterev, 2005, Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury, Nat. Chem. Biol., 1, 112, 10.1038/nchembio711 Degterev, 2008, Identification of RIP1 kinase as a specific cellular target of necrostatins, Nat. Chem. Biol., 4, 313, 10.1038/nchembio.83 Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, 29, 15, 10.1093/bioinformatics/bts635 Dondelinger, 2013, RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition, Cell Death Differ., 20, 1381, 10.1038/cdd.2013.94 Dondelinger, 2015, NF-κB-independent role of IKKα/IKKβ in preventing RIPK1 kinase-dependent apoptotic and necroptotic cell death during TNF signaling, Mol. Cell, 60, 63, 10.1016/j.molcel.2015.07.032 Dziedzic, 2018, ABIN-1 regulates RIPK1 activation by linking Met1 ubiquitylation with Lys63 deubiquitylation in TNF-RSC, Nat. Cell Biol., 20, 58, 10.1038/s41556-017-0003-1 Freischmidt, 2017, Association of mutations in TBK1 with sporadic and familial amyotrophic lateral sclerosis and frontotemporal dementia, JAMA Neurol., 74, 110, 10.1001/jamaneurol.2016.3712 Geng, 2017, Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis, Nat. Commun., 8, 359, 10.1038/s41467-017-00406-w Ghasemi, 2017, Genetics of amyotrophic lateral sclerosis, Cold Spring Harb. Perspect. Med., 8, a024125, 10.1101/cshperspect.a024125 Hawley, 2014, Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells, Biochem. J., 459, 275, 10.1042/BJ20131344 Ishii, 2008, TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines, Nature, 451, 725, 10.1038/nature06537 Ito, 2016, RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS, Science, 353, 603, 10.1126/science.aaf6803 Jaco, 2017, MK2 phosphorylates RIPK1 to prevent TNF-induced cell death, Mol. Cell, 66, 698, 10.1016/j.molcel.2017.05.003 Kendall, 2007, Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer, Proc. Natl. Acad. Sci. USA, 104, 16663, 10.1073/pnas.0708286104 Kuai, 2004, NAK is recruited to the TNFR1 complex in a TNFalpha-dependent manner and mediates the production of RANTES: identification of endogenous TNFR-interacting proteins by a proteomic approach, J. Biol. Chem., 279, 53266, 10.1074/jbc.M411037200 Lall, 2017, Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia, J. Clin. Invest., 127, 3250, 10.1172/JCI90607 Li, 2011, RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome, BMC Bioinformatics, 12, 323, 10.1186/1471-2105-12-323 Loerch, 2008, Evolution of the aging brain transcriptome and synaptic regulation, PLoS ONE, 3, e3329, 10.1371/journal.pone.0003329 Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol., 15, 550, 10.1186/s13059-014-0550-8 Matsui, 2006, Cutting edge: role of TANK-binding kinase 1 and inducible IkappaB kinase in IFN responses against viruses in innate immune cells, J. Immunol., 177, 5785, 10.4049/jimmunol.177.9.5785 McCartney, 2016, Activation and inhibition of Snf1 kinase activity by phosphorylation within the activation loop, Biochim. Biophys. Acta, 1864, 1518, 10.1016/j.bbapap.2016.08.007 Meng, 2018, Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis, Proc. Natl. Acad. Sci. USA, 115, E2001, 10.1073/pnas.1722013115 Menon, 2017, p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection, Nat. Cell Biol., 19, 1248, 10.1038/ncb3614 Mihaly, 2014, TAK1 control of cell death, Cell Death Differ., 21, 1667, 10.1038/cdd.2014.123 Morioka, 2014, TAK1 kinase switches cell fate from apoptosis to necrosis following TNF stimulation, J. Cell Biol., 204, 607, 10.1083/jcb.201305070 Neumann, 2006, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Science, 314, 130, 10.1126/science.1134108 Newton, 2004, Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4, Mol. Cell. Biol., 24, 1464, 10.1128/MCB.24.4.1464-1469.2004 Niccoli, 2017, Ageing as a risk factor for ALS/FTD, Hum. Mol. Genet., 26, R105, 10.1093/hmg/ddx247 Ofengeim, 2015, Activation of necroptosis in multiple sclerosis, Cell Rep., 10, 1836, 10.1016/j.celrep.2015.02.051 Ofengeim, 2017, RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease, Proc. Natl. Acad. Sci. USA, 114, E8788, 10.1073/pnas.1714175114 Onyike, 2013, The epidemiology of frontotemporal dementia, Int. Rev. Psychiatry, 25, 130, 10.3109/09540261.2013.776523 Perry, 1993, Altered antigen expression of microglia in the aged rodent CNS, Glia, 7, 60, 10.1002/glia.440070111 Picelli, 2013, Smart-seq2 for sensitive full-length transcriptome profiling in single cells, Nat. Methods, 10, 1096, 10.1038/nmeth.2639 Polykratis, 2014, Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo, J. Immunol., 193, 1539, 10.4049/jimmunol.1400590 Pomerantz, 1999, NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase, EMBO J., 18, 6694, 10.1093/emboj/18.23.6694 Sanjana, 2014, Improved vectors and genome-wide libraries for CRISPR screening, Nat. Methods, 11, 783, 10.1038/nmeth.3047 Sato, 2005, Essential function for the kinase TAK1 in innate and adaptive immune responses, Nat. Immunol., 6, 1087, 10.1038/ni1255 Sun, 2012, Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase, Cell, 148, 213, 10.1016/j.cell.2011.11.031 Weinlich, 2017, Necroptosis in development, inflammation and disease, Nat. Rev. Mol. Cell Biol., 18, 127, 10.1038/nrm.2016.149 White, 2016, Amyotrophic lateral sclerosis: recent genetic highlights, Curr. Opin. Neurol., 29, 557, 10.1097/WCO.0000000000000367 Xie, 2013, Structural basis of RIP1 inhibition by necrostatins, Structure, 21, 493, 10.1016/j.str.2013.01.016 Zhang, 2014, An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex, J. Neurosci., 34, 11929, 10.1523/JNEUROSCI.1860-14.2014 Zimmermann, 2001, How cells die: apoptosis pathways, J. Allergy Clin. Immunol., 108, S99, 10.1067/mai.2001.117819